MedPath

Efficacy and Safety Evaluation of Splendor-X SMART System for hair removal

Conditions
Excessive hair growth, hirsutism
Registration Number
NL-OMON29490
Lead Sponsor
umenis Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1.All skin types: I-VI
2.male or female
3.Age – 18-50 years of age
4.Having two suitable treatment areas (legs, thighs, back, Chest, axillae, bikini, front of the neck or abdomen) with dark brown or black hair appropriate for hair removal;

Exclusion Criteria

1.Previous hair removal procedures at intended areas
2.Active infections in the treated area;
3.Dysplastic nevi in the treatment area;
4.Significant concurrent skin conditions or any inflammatory skin conditions;
5.Active cold sores, open lacerations or abrasions in the treated area;
6.Chronic or cutaneous viral, fungal, or bacterial diseases;
7.Intense tan, Deep suntan, recent suntan within 2 weeks, sunburn or artificially tanned skin;
8.Current cancer, history of skin cancer or pre-cancerous lesions at the treatment areas;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Feasibility of hair removal treatment with the Splendor-X SMART laser platform for hair removal treatment for all skin types.
Secondary Outcome Measures
NameTimeMethod
•Percent change of number of hairs before and after 3 treatments with the Splendor-X SMART system as compared to Splendor-X.<br>•Difference between the Splendor-X SMART system and the subjective physician judgment on standard assessments of skin characteristics.<br>•Splendor-X SMART melanin and erythema measurements as compared to MX18 for each treatment.<br>
© Copyright 2025. All Rights Reserved by MedPath